Discontinued — last reported Q4 '24
Danaher Life Sciences — Goodwill, Acquired During Period remained flat by 0.0% to $76.25M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 92.1%, from $962.75M to $76.25M. Over 2 years (FY 2021 to FY 2024), Life Sciences — Goodwill, Acquired During Period shows a downward trend with a -79.2% CAGR.
High values indicate active M&A activity, suggesting a growth strategy focused on buying market share or new technologies.
The amount of goodwill recognized specifically from business acquisitions completed within the Life Sciences segment dur...
Used by investors to track the pace of inorganic growth compared to industry peers with similar M&A strategies.
dhr_segment_life_sciences_goodwill_acquired_during_period| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.77B | $1.77B | $1.77B | $43.00M | $962.75M | $962.75M | $962.75M | $962.75M | $76.25M | $76.25M | $76.25M | $76.25M |
| QoQ Change | — | +0.0% | +0.0% | -97.6% | >999% | +0.0% | +0.0% | +0.0% | -92.1% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | -97.6% | — | — | — | >999% | -92.1% | -92.1% | -92.1% | -92.1% |